Gastric cancer development after helicobacter pylori eradication therapy: A new form of gastric neoplasia

Digestion

Volumn 85, Issue 1, 2012, Pages 61-67

  Matsuo, Taiji ^a   Ito, Masanori ^a,b   Tatsugami, Masana ^a   Boda, Tomoyuki ^a   Takata, Shunsuke ^b   Tanaka, Shinji ^b   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Endoscopy; Gastric mucus; Gastritis; Helicobacter pylori; Wnt5a signal

Indexed keywords

MUCIN 2; WNT5A PROTEIN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ERADICATION THERAPY; FEMALE; GENE EXPRESSION; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUCUS; PRIORITY JOURNAL; STOMACH CANCER; TUMOR;

AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 84855375982     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000335260     Document Type: Article

References (25)

1. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perezperez GI, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese-Americans in Hawaii. N Engl J Med 1991; 325: 1132-1136.
2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131.
3. Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M: Helicobacter pylori infection enhances N-methyl-N-nitrosourea- induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 1998; 58: 2067-2069. (Pubitemid 28232885)
4. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans: Helicobacter pylori ; in: Schistosomes , Liver Flukes , and Helicobacter pylori . Lyon, International Agency for Research on Cancer, 1994, pp 177-240.
5. Goodman KJ, Cockburn M: The role of epidemiology in understanding the health effects of Helicobacter pylori . Epidemiology 2001; 12: 266-271. (Pubitemid 32167765)
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
7. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M, Japan Gast Study Group: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet 2008; 372: 392-397.
8. Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, Takamura A, Kitamura S, Matsuo T, Tanaka S, Haruma K, Chayama K: Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol 2009; 44: 365-371.
9. Graham DY, Asaka M: Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol 2010; 45: 1-8.
10. Takata S, Ito M, Yoshihara M, Tanaka S, Imagawa S, Haruma K, Chayama K: Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori : preliminary report. J Gastroenterol and Hepatol 2007; 22: 571-576. (Pubitemid 46434988)
11. Haruma K, Komoto K, Kawaguchi H, Okamoto S, Yoshihara M, Sumii K, Kajiyama G: Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection. Am J Gastroenterol 1995; 90: 1107-1110.
12. Ito M, Tanaka S, Takata S, Oka S, Imagawa S, Ueda H, Egi Y, Kitadai Y, Yasui W, Yoshihara M, Haruma K, Chayama K: Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther 2005; 21: 559-566. (Pubitemid 40381507)
13. Kikuchi A: Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 2003; 94: 225-229. (Pubitemid 36575886)
14. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W, Kikuchi A: Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006; 66: 10439-10448. (Pubitemid 44799765)
15. Japanese Classification of Gastric Carcinoma March 2010 (ed 14). Japanese Gastric Cancer Association, 2010.
16. Ito M, Haruma K, Kamada T, Kitadai Y, Hidaka T, Tsuda T, Komatsu H, Fukuhara T, Yoshihara M, Chayama K: Reduction in the incidence of Helicobacter pylori -associated carcinoma in Japanese young adults. Oncol Rep 2001; 8: 633-636. (Pubitemid 33758467)
17. Sasaki A, Kitadai Y, Ito M, Tanaka S, Yoshihara M, Haruma K, Chayama K: Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach. Oncology 2004; 66: 379-387. (Pubitemid 39194360)
18. Morgner A, Miehlke S, Stolte M, Neubauer A, Alpen B, Thiede C, Klann H, Hierlmeier FX, Ell C, Ehninger G, Bayerdorffer E: Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol 2001; 7: 248-253 (Pubitemid 32377479)
19. Haruma K, Mihara M, Okamoto E, Kusunoki H, Hananoki M, Tanaka S, Yoshihara M, Sumi K, Kajiyama G: Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus -evaluation of 24-hour pH monitoring. Aliment Pharmacol Ther 1999; 13: 155-162. (Pubitemid 29090009)
20. Naito Y, Ito M, Watanabe T, Suzuki H: Biomarkers in patients with gastric inflammation: a systematic review. Digestion 2005; 72: 164-180. (Pubitemid 41507277)
21. Yamamoto K, Kato M, Takahashi M, Haneda M, Shinada K, Nishida U, Yoshida T, Sonoda N, Ono S, Nakagawa M, Mori Y, Nakagawa S, Mabe K, Shimizu Y, Moriya J, Kubota K, Matsuno Y, Shimoda T, Watanabe H, Asaka M: Clinicopathological analysis of earlystage gastric cancers detected after successful eradication of Helicobacter pylori . Helicobacter 2011; 16: 210-216.
22. Tsukuma H, Oshima A, Narahara H, Morii T: Natural history of early gastric cancer: a non-concurrent, long-term, follow-up study. Gut 2000; 47: 618-621.
23. Haruma K, Suzuki T, Tsuda T, Yoshihara M, Sumii K, Kajiyama G: Evaluation of tumor growth rate in patients with early gastric carcinoma of the elevated type. Gastrointest Radiol 1991; 16: 289-292.
24. Shiotani A, Nishi R, Uedo N, Iishi H, Tsutsui H, Ishii M, Imamura H, Kamada T, Hata J, Haruma K: Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer. Digestion 2010; 81: 223-230.
25. Sasaki A, Kitadai Y, Ito M, Sumii M, Tanaka S, Yoshihara M, Haruma K, Chayama K: Helicobacter pylori infection influences tumor growth of human gastric carcinomas. Scand J Gastroenterol 2003; 38: 153-158. (Pubitemid 36349926)